Equity Details
Price & Market Data
Price: $0.0654
Daily Change: +$0.0154 / 23.55%
Daily Range: $0.05 - $0.0654
Market Cap: $4,727,007
Daily Volume: 6,004
Performance Metrics
1 Week: -30.17%
1 Month: -16.67%
3 Months: 25.00%
6 Months: -42.00%
1 Year: -52.43%
YTD: 14.60%
About Nymox Pharmaceutical Corporation (NYMXF)
Keep track of Nymox Pharmaceutical Corporation (NYMXF)'s market journey. Priced at 0.0654, the stock reflects a daily movement of +$0.0154 / 23.55%. With a market cap of 4,727,007, explore its full spectrum of performance from YTD to 1-year.
Details
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.